Cargando…

Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation

Epigenomic changes may either cause disease or modulate its expressivity, adding a layer of complexity to mendelian diseases. X‐linked adrenoleukodystrophy (X‐ALD) is a rare neurometabolic condition exhibiting discordant phenotypes, ranging from a childhood cerebral inflammatory demyelination (cALD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlüter, Agatha, Sandoval, Juan, Fourcade, Stéphane, Díaz‐Lagares, Angel, Ruiz, Montserrat, Casaccia, Patrizia, Esteller, Manel, Pujol, Aurora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857458/ https://www.ncbi.nlm.nih.gov/pubmed/29476661 http://dx.doi.org/10.1111/bpa.12595

Ejemplares similares

Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy
por: López-Erauskin, Jone, et al.
Publicado: (2011)

Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy
por: Schlüter, Agatha, et al.
Publicado: (2012)

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy
por: Launay, Nathalie, et al.
Publicado: (2014)

Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy
por: López-Erauskin, Jone, et al.
Publicado: (2012)

Complete loss of KCNA1 activity causes neonatal epileptic encephalopathy and dyskinesia
por: Verdura, Edgard, et al.
Publicado: (2020)

Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy
por: Launay, Nathalie, et al.
Publicado: (2016)

Aberrant regulation of the GSK‐3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy
por: Ranea‐Robles, Pablo, et al.
Publicado: (2018)

Glutathione imbalance in patients with X-linked adrenoleukodystrophy()
por: Petrillo, Sara, et al.
Publicado: (2013)

A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy
por: Rodríguez‐Palmero, Agustí, et al.
Publicado: (2020)

A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases
por: Verdura, Edgard, et al.
Publicado: (2019)

Phylogenomic Evidence for a Myxococcal Contribution to the Mitochondrial Fatty Acid Beta-Oxidation
por: Schlüter, Agatha, et al.
Publicado: (2011)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2023)

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
por: Toll, Agustí, et al.
Publicado: (2016)

Anti-oxidant MitoQ rescue of AWB chemosensory neuron impairment in a C. elegans model of X-linked Adrenoleukodystrophy
por: Guha, Sanjib, et al.
Publicado: (2021)

PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease
por: Schlüter, Agatha, et al.
Publicado: (2007)

Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain
por: Shen, Siming, et al.
Publicado: (2005)

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
por: Pineda, Begoña, et al.
Publicado: (2019)

Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
por: Gondcaille, Catherine, et al.
Publicado: (2005)

SIRT2 in age-related neurodegenerative disorders
por: Fourcade, Stéphane, et al.
Publicado: (2018)

PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells
por: Dansu, David K., et al.
Publicado: (2022)

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy
por: Zhou, Jie, et al.
Publicado: (2021)

Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
por: Casasnovas, Carlos, et al.
Publicado: (2019)

Bálint syndrome as the presenting manifestation of adrenoleukodystrophy
por: Ghosh, R., et al.
Publicado: (2023)

Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes
por: Douvaras, Panagiotis, et al.
Publicado: (2016)

Childhood cerebral adrenoleukodystrophy
por: Mittal, Aliza, et al.
Publicado: (2014)

Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy
por: Martinović, Ksenija, et al.
Publicado: (2023)

Identification of a Gene Regulatory Network Necessary for the Initiation of Oligodendrocyte Differentiation
por: Swiss, Victoria A., et al.
Publicado: (2011)

PeroxisomeDB 2.0: an integrative view of the global peroxisomal metabolome
por: Schlüter, Agatha, et al.
Publicado: (2010)

Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor
por: Szczesna, Karolina, et al.
Publicado: (2014)

Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance
por: Fourcade, Stéphane, et al.
Publicado: (2017)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Pathophysiology of X-linked adrenoleukodystrophy()
por: Berger, J., et al.
Publicado: (2014)

Multiple sclerosis in an adrenoleukodystrophy carrier
por: Jenkins, Thomas, et al.
Publicado: (2011)

Anesthesia in a child with adrenoleukodystrophy
por: Yang, Hun-Ju, et al.
Publicado: (2014)

Evolution of adrenoleukodystrophy model systems
por: Montoro, Roberto, et al.
Publicado: (2021)

Epigenome-wide association study of COVID-19 severity with respiratory failure
por: Castro de Moura, Manuel, et al.
Publicado: (2021)

Loss of seryl-tRNA synthetase (SARS1) causes complex spastic paraplegia and cellular senescence
por: Verdura, Edgard, et al.
Publicado: (2022)

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011)

X-linked adrenoleukodystrophy in 8 patients
por: Meng, Zhe, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bsaancnsmfgjddapvs5k2oa37r